Literature DB >> 8163996

Lessons from a remarkable family with dopa-responsive dystonia.

G Harwood1, R Hierons, N A Fletcher, C D Marsden.   

Abstract

A family is described in which dopa-responsive dystonia affected six members and segregated in an autosomal dominant fashion. Patients either presented in childhood with dystonia of the legs, going to develop parkinsonism and pseudo-pyramidal deficits, or in adult life with parkinsonian tremor and rigidity, with pseudo-pyramidal signs. Remarkably, in the three cases with childhood onset the symptoms and signs of the condition were abolished 36 to 52 years later by small doses of levodopa. No long term side effects of levodopa have appeared after 15 years of treatment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8163996      PMCID: PMC1072876          DOI: 10.1136/jnnp.57.4.460

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  19 in total

1.  Hereditary Parkinsonism-dystonia with sustained control by L-DOPA and anticholinergic medication.

Authors:  N Allen; W Knopp
Journal:  Adv Neurol       Date:  1976

2.  Dopa-responsive dystonia: [18F]dopa positron emission tomography.

Authors:  G V Sawle; K L Leenders; D J Brooks; G Harwood; A J Lees; R S Frackowiak; C D Marsden
Journal:  Ann Neurol       Date:  1991-07       Impact factor: 10.422

3.  Pallido-pyramidal syndrome treated with levodopa.

Authors:  G Horowitz; J Greenberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-03       Impact factor: 10.154

4.  Tyrosine hydroxylase and levodopa responsive dystonia.

Authors:  N A Fletcher; I J Holt; A E Harding; T G Nygaard; J Mallet; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-01       Impact factor: 10.154

5.  Dopa-responsive dystonia: long-term treatment response and prognosis.

Authors:  T G Nygaard; C D Marsden; S Fahn
Journal:  Neurology       Date:  1991-02       Impact factor: 9.910

6.  REMARKABLE RESPONSE TO BENZHEXOL HYDRO-CHLORIDE (ARTANE) IN CHILDREN WITH AN UNUSUAL PROGRESSIVE STRIATAL SYNDROME: A REPORT ON 3 CASES.

Authors:  E S MUCKLOW; H T METZ
Journal:  Dev Med Child Neurol       Date:  1964-12       Impact factor: 5.449

7.  Tetrahydrobiopterin in dystonia: identification of abnormal metabolism and therapeutic trials.

Authors:  P A LeWitt; L P Miller; R A Levine; W Lovenberg; R P Newman; A Papavasiliou; A Rayes; R Eldridge; R S Burns
Journal:  Neurology       Date:  1986-06       Impact factor: 9.910

8.  Dystonia musculorum deformans in siblings; treated with artane (trihexyphenidyl).

Authors:  B D CORNER
Journal:  Proc R Soc Med       Date:  1952-07

9.  Dihydrobiopterin synthesis defect: an adult with diurnal fluctuation of symptoms.

Authors:  K Tanaka; M Yoneda; T Nakajima; T Miyatake; M Owada
Journal:  Neurology       Date:  1987-03       Impact factor: 9.910

10.  Fluctuating dystonia and allied syndromes.

Authors:  N Gordon
Journal:  Neuropediatrics       Date:  1982-08       Impact factor: 1.947

View more
  9 in total

1.  Occurrence of GCH1 gene mutations in a group of Indian dystonia patients.

Authors:  Tufan Naiya; Amar K Misra; Arindam Biswas; Shyamal K Das; Kunal Ray; Jharna Ray
Journal:  J Neural Transm (Vienna)       Date:  2012-02-29       Impact factor: 3.575

2.  GTP cyclohydrolase I mutations in patients with dystonia responsive to anticholinergic drugs.

Authors:  P R Jarman; O Bandmann; C D Marsden; N W Wood
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-09       Impact factor: 10.154

3.  A Severe l-Dopa Responsive Dystonia With Slow and Continuous Improvement in a Patient With a Novel Mutation in the Tyrosine Hydroxylase Gene.

Authors:  Christian Marques Couto; Antônio Pedro Vargas; Fernando Dos Santos Coimbra; Olimar Leite de Assis Cunha; Lucia Willadino Braga
Journal:  Mov Disord Clin Pract       Date:  2019-05-02

Review 4.  Dopa-responsive dystonia--clinical and genetic heterogeneity.

Authors:  Subhashie Wijemanne; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2015-06-23       Impact factor: 42.937

5.  Treatment of generalized dystonia.

Authors:  Naomi Lubarr; Susan Bressman
Journal:  Curr Treat Options Neurol       Date:  2011-06       Impact factor: 3.598

Review 6.  Childhood onset generalised dystonia can be modelled by increased gain in the indirect basal ganglia pathway.

Authors:  T D Sanger
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-11       Impact factor: 10.154

Review 7.  Clinical spectrum of dopa-responsive dystonia and related disorders.

Authors:  Woong-Woo Lee; Beom Seok Jeon
Journal:  Curr Neurol Neurosci Rep       Date:  2014-07       Impact factor: 5.081

8.  Genetic diagnosis of two dopa-responsive dystonia families by exome sequencing.

Authors:  Zhan-fang Sun; Yu-han Zhang; Ji-feng Guo; Qi-ying Sun; Jun-pu Mei; Han-lin Zhou; Li-ping Guan; Jin-yong Tian; Zheng-mao Hu; Jia-da Li; Kun Xia; Xin-xiang Yan; Bei-sha Tang
Journal:  PLoS One       Date:  2014-09-02       Impact factor: 3.240

9.  Series of Dopa Responsive Dystonia Masquerading as Other Diseases with Short Review.

Authors:  Shubhankar Mishra; Ashok K Mallick; Debasish Panigrahy; Priyabrata Nayak; Nihar R Biswal
Journal:  J Pediatr Neurosci       Date:  2021-01-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.